Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 4Phase 3 2Phase 1/2 2

Status

Completed 2

Sponsor Class

INDUSTRY 5OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 2

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × methyl 5-aminolevulinate × Clear all
NCT02373371 2025-07-29

Actinic Keratoses Treatment With Metvix® in Combination With Light

University Hospital, Limoges

Phase 3 Completed
26 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT00926952 2011-09-09

Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion

Innovaderm Research Inc.

Phase 3 Completed
20 enrolled 21 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡